ORMP

Oramed Pharmaceuticals Inc.

Price

$3.80

return (12m)

p/e

1.51

p/bv

0.70

DIVIDEND YIELD

6.15%

ORMP price

Oramed Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ORMP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ORMP

Valuation

P/E

1.51

Sector -4.15

Industry -4.15

P/BV

0.70

Sector 2.06

Industry 2.06

P/Revenue (PSR)

Sector -4.16

Industry -4.16

EV/EBITDA

-27.78

Sector -241.86

Industry -241.86

EV/EBIT

-27.55

Sector -671.75

Industry -671.75

P/EBITDA

2.11

Sector -4.30

Industry -4.30

P/EBIT

2.12

Sector -4.35

Industry -4.35

P/Total Assets

0.62

Sector 1.46

Industry 1.46

P/Net Current Assets

4.43

Sector -12.67

Industry -12.67

P/Working Capital

2.89

Sector -12.58

Industry -12.58

EPS

2.68

Sector -2.19

Industry -2.19

BVPS

5.81

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

0.00%

Sector 36.44%

Industry 36.44%

EBITDA Margin

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

0.00%

Sector -38.78%

Industry -38.78%

Net Profit Margins

0.00%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

46.17%

Sector -67.01%

Industry -67.01%

ROA

40.92%

Sector -66.28%

Industry -66.28%

ROIC

-7.52%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

6.15%

Sector -

Industry -

Payout

9.29%

Sector -

Industry -

Debt

Current Ratio

6.45

Sector 2.90

Industry 2.90

Net Debt / EBITDA

18.14

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

17.99

Sector -3.79

Industry -3.79

Net Debt / Equity

-0.28

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.00

Sector 0.00

Industry 0.00

Equity/Assets

0.89

Sector 0.42

Industry 0.42

Liabilities/Assets

0.11

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Oramed Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$3.80

Fair Value

$18.72

Upside Return potential.

392.56%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ORMP

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ORMP Oramed Pharmaceuticals Inc.	$3.80	93.18%	6.15%	1.51	0.70	46.17%	0.00%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ORMP Historical Dividends

current DY: 6.15%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	01/16/2026	01/26/2026	0.25000000

ABOUT Oramed Pharmaceuticals

Oramed Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

24 years

Founded: 2002

2007

Time since IPO - 19 years

12

Employees

Oramed Pharmaceuticals Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $166.67 million, with shareholders equity totaling $238.28 million.

The company employs approximately 12 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Oramed Pharmaceuticals Inc. reported $- in revenue, generating net income of $110.01 million.

Key financial metrics include a P/E ratio of 1.51, a price-to-book (P/B) ratio of 0.70, and a trailing twelve-month dividend yield of 6.15%.

The company trades under the ticker ORMP.

Market cap

$166.67 million

Net worth

$238.28 million

$238,280,000.00

Assets

$268.85 million

$268,850,000.00

Total Shares Outstanding

41.00 million

41,000,000

Average Daily Trading Volume

$335.23 Thousand

$335,228.18

Sector

Healthcare

Industry

Biotecnologia

ORMP

ORMP revenue and profits

Financial Results ORMP

DRAG THE FRAME TO SEE MORE DATA

ORMP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14